Celgene files TM claim against Beacon over psoriasis drug

09-01-2018

Celgene files TM claim against Beacon over psoriasis drug

txking / iStockphoto.com

Global biopharmaceutical company Celgene Corporation, headquartered in New Jersey, has filed a claim against oncology company Beacon Pharmaceuticals, situated in Bangladesh, for trademark infringement.


Intellectual property, Celgene, Beacon, trademark infringement, Otezla, apremilast

LSIPR